anti-fibroblast-activation protein antibody radiotracers (Hoffmann-La Roche/Radboud University)

N/A

Report date: 2025/11/20 13:28:35

Base Information

Drug Nameanti-fibroblast-activation protein antibody radiotracers (Hoffmann-La Roche/Radboud University)
Drug Alias Name(111)In-labeled anti-FAP antibody 28H1111In-28H1(111)In-28H1
ClassificationRadiation-emitting products > Nuclides > Indium > 111InRadiation-emitting products > Radionuclide Drug ConjugatesDiagnostic agent (In vivo) +[5] 
Mechanisms of ActionFibroblast activation protein alpha inhibitors
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsArthritis, RheumatoidMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRadboud UniversityF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsArthritis, RheumatoidMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A